Yuan Wei, Liu Sheng, Lu Li, Feng Juan, He Xin
Department of Orthopedics, First Hospital of China Medical University Shenyang, China.
Department of Infectious Disease, First Hospital of China Medical University Shenyang, China.
Am J Transl Res. 2020 May 15;12(5):2110-2117. eCollection 2020.
The coronavirus disease 2019 (COVID-19) has been ongoing outbreak and declared as a global public health emergency by the World Health Organization. Severe and critical COVID-19 has high fatality rate due to complications like acute respiratory distress syndrome, acute respiratory failure or multiple organ failure. So far, there have been mounting research on the epidemiological and clinical characteristics of COVID-19. However, the information regarding treatment of severe and critical COVID-19 is limited. The current study reviewed published evidence of clinical interventions of severe and critical COVID-19, aiming to provide an up-to-date reference for further clinical treatment.
2019年冠状病毒病（COVID-19）疫情持续爆发，世界卫生组织已将其宣布为全球突发公共卫生事件。重型和危重型COVID-19因急性呼吸窘迫综合征、急性呼吸衰竭或多器官功能衰竭等并发症而具有较高的病死率。到目前为止，关于COVID-19流行病学和临床特征的研究越来越多。然而，关于重型和危重型COVID-19治疗的信息有限。本研究回顾了已发表的重型和危重型COVID-19临床干预证据，旨在为进一步的临床治疗提供最新参考。
